《新股表现》Ritamix(01936.HK)暗盘高开30%报1.3元
根据辉立交易平台显示,明天挂牌的Ritamix(01936.HK)暗盘高开30%报1.3元获承接,曾升至1.6元,现造1.45元,较上市价1元,高45%,成交241万股。
Ritamix是一间扎根及专注服务马来西亚农业逾37年的公司,主要从事分销动物饲料添加剂与较少人类食品配料,以及生产动物饲料添加剂预混料。是次来港上市共发售1.25亿股,其中10%公开发售获4.3倍超购,股份以招股范围(1-1.2元)下限定价,料集资净额7,240万元,主要用作建立新厂房提高产能、用作潜在收购或与同业进行商业合作、以及建立内部实验和安装ERP系统等。上市保荐人大有融资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.